Philogen in the News
Articles about Philogen in newspapers, magazines, websites and podcasts.
2025
Sole e tumori della pelle, una nuova terapia rivoluziona la cura del basalioma
NapoliToday··Italiano
2024
Melanoma: immunoterapico locale uccide il tumore e “recluta” cellule per contrastare metastasi e recidive
Sole 24 ore – Sanità··Italiano
Melanoma: l’iniezione locale pre-intervento riduce del 40% il rischio di recidive e metastasi
Sole 24 ore – Sanità··Italiano
Behind the Pharma Curtain: Navigating Drug Trials and Cancer Research with Professor Dario Neri
How It Tiks – Spotify·
Le ambizioni europee di Philogen. Così vince la ricerca Made in Italy
·Italiano
2023
Schon über 180 unheilbare Krebspatienten behandelt: Eine unbekannte Schweizer Firma steht vor dem Durchbruch
English translation: Already treated over 180 incurable cancer patients: An unknown Swiss company is on the verge of a breakthrough
TAGBLATT··Deutsch
Gruppo Philogen: le nuove frontiere della medicina oncologica puntano sul targeting molecolare
English translation: New frontiers in cancer medicine aim at molecular targeting
Sole 24, Sanità 24··Italiano
BioBoss Podcast #60 – Dario Neri: co-founder & CEO, Philogen
BioBoss·
Neue Niedermolekulare-Wirkstoffe-ML-Allianz
English translation: New low-molecular-weight active substance ML alliance
CHEMIEXTRA··Deutsch
Dario Neri e la corsa di Philogen. Biotech, Industria da esportare
English translation: Dario Neri and the Philogen race. Biotech, Industry to be exported
Corriere della Sera··Italiano
Philogen Announces Clinical Trial Collaboration with MSD
Wallstreet Online·
Philogen si presenta alla città, Duccio Neri critico sul Biotecnopolo: “La politica ne stia fuori”
English translation: Philogen introduces itself to the city, Duccio Neri critical of Biotecnopolo: “Politics stay out of it”
Sienanews··Italiano
Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe, Australia, New Zealand
la Repubblica·
Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe, Australia, New Zealand
The Economic Times·
Antibody-cytokine fusion breathes new life into glioblastoma therapy
Science Translational Medicine·
Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clinical trials advance
STAT·
New opportunities for small molecules in cancer
MedNous·
Using ML with DEL: Philogen and Google Partner in New Study
Oxford Global·
Industrial PhD: My way to go?
Chem (Cell)·
2022
The Philogen Family Prepares For Commercialization
Bioprocess Online·
Philogen announces enrolment of 214 patients in the Nidlegy™ Phase III European clinical trial for the treatment of locally advanced melanoma
BioSpace·
Diagnosi in oncologia: al via una partnership tra Philochem e Bracco Imaging
English translation: Diagnosis in oncology: partnership between Philochem and Bracco Imaging kicks off”
AboutPharma··Italiano
Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications
GlobeNewsWire·
Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)
BioSpace·
2021
Philogen Announces New Collaboration with Janssen To Discover Small Molecule Therapeutics
Seeking Alpha·
Philogen, una realtà senese alla conquista di Piazza Affari
Radio Siena TV··Italiano
Philogen Announces Publication of Best-in-Class FAP-Targeting Small Molecule Ligand (OncoFAP) in PNAS
BioSpace·
Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry
BioSpace·
Philogen, a Piazza Affari la prima Ipo del 2021
Blue Rating··Italiano
2020
Philogen guida il ritorno delle Ipo a Piazza Affari
il Sole 24 ore··Italiano
“Always ask the important questions”
ETH·
New immunocytokine therapy shows promise for glioblastoma
BioTechScope·
Philogen Announces Option Exercise by Janssen
BioSpace·
2019
Che cosa fa Philogen, la biotech italiana che ha chiuso un aumento di capitale da 62 milioni di euro
StartupItalia··Italiano
Italian cancer startup Philogen gets off an impressive $70M funding round
Fierce Biotech·
Philogen who? A low profile but pharma-connected Italian-Swiss hybrid steps out with $68M for a final push over the PhIII finish line
Endpoint·
Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma
Labiotech·
Philogen Announces Collaboration
BioSpace·
Philogen Announces Collaboration With Celgene
BioSpace·
Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation
BioSpace·
2018
Philogen Announces Exercise of Options Within the License Agreement With AbbVie in the Field of Immuno-Inflammation
NewsWire·
2017
Philogen S.p.A. Announces Authorization From FDA Of A Pivotal Registration Trial In U.S.A. For The Treatment Of Resectable Melanoma
BioSpace·
Philogen S.p.A. Announces Research Collaboration With Servier n The Field Of DNA-Encoded Chemistry
BioSpace·
Boehringer Ingelheim to Leverage Philogen’s DNA-Encoded Library Platform
Inside Precision Medicine·
2016
Philogen S.p.A. Announces Collaboration With Johnson & Johnson Innovation
BioSpace·
Philogen S.p.A. Announces Expanded Research And Development Agreement With AbbVie
BioSpace·
Philogen S.p.A. Announces Commencement Of Phase III Pivotal Trial In Melanoma
BioSpace·
Philogen S.p.A. Announces Exercise Of Options Within The License Agreement With Pfizer For The Development And Potential Commercialization Of Multiple Antibody Drug Conjugates (ADCs) And Targeted Technologies
CNN Money·
2013
Italy’s Philogen signs drug licence deal with Pfizer
Reuters·